Showing results (881-890 of 4,514) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|October 4, 2012
Psychosocial and spiritual problems of terminally ill patients in Kerala, IndiaFrank Elsner, Johanna Schmidt, M R Rajagopal, et al.
Future Oncology (London, England)|August 24, 2022
The role of UXT in tumors and prospects for its application in hepatocellular carcinomaZhengwang Wang, Shaojian Mo, Pengzhe Han, et al.
Future Oncology (London, England)|August 26, 2022
The implications from the interplay of neoadjuvant chemoradiotherapy and the immune microenvironment in rectal cancerMengyuan Shi, Yongkang Chen, Dengbo Ji
Future Oncology (London, England)|August 26, 2022
Efficacy of the dexamethasone-sparing triplet regimen for preventing cisplatin-induced emesis: a combined analysisLuigi Celio, Erminio Bonizzoni, Elena Montani, et al.
Future Oncology (London, England)|November 8, 2022
Psychometric properties of the 37-item Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) scaleAline Hajj, Pascale Salameh, Rita Khoury, et al.
Future Oncology (London, England)|November 8, 2022
The genetic polymorphisms in the SP4 gene and the risk of gastric cancerYihan Cui, Wenjin Wang, Peipei Luo, et al.
Future Oncology (London, England)|August 15, 2022
A new biomarker to enhance the radiosensitivity of hepatocellular cancer: miRNAsJu Guo, Kai Jin, Ting Tang, et al.
Future Oncology (London, England)|August 15, 2022
Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trialKang Wang, Hong-Ming Yu, Yan-Jun Xiang, et al.
Future Oncology (London, England)|August 5, 2022
Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in GreeceSofia Lampaki, Giannis Mountzios, Vassilis Georgoulias, et al.
Future Oncology (London, England)|August 8, 2022
Plain language summary of outcomes in people treated for lung squamous cell cancer with afatinib after receiving pembrolizumab with chemotherapyEdward S Kim
Pageof 452